Reduced infarct size in neuroglobin-null mice after experimental stroke in vivo

BACKGROUND: Neuroglobin is considered to be a novel important pharmacological target in combating stroke and neurodegenerative disorders, although the mechanism by which this protection is accomplished remains an enigma. We hypothesized that if neuroglobin is directly involved in neuroprotection, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Raida, Zindy, Hundahl, Christian Ansgar, Kelsen, Jesper, Nyengaard, Jens Randel, Hay-Schmidt, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487987/
https://www.ncbi.nlm.nih.gov/pubmed/22901501
http://dx.doi.org/10.1186/2040-7378-4-15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487987/
https://www.ncbi.nlm.nih.gov/pubmed/22901501
http://dx.doi.org/10.1186/2040-7378-4-15

Ejemplares similares